VNDA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Vanda Pharmaceuticals Inc

NASDAQ | VNDA

5.23

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$313.76M

Market Cap

-

P/E Ratio

-1.14

EPS

$5.59

52 Week High

$3.80

52 Week Low

HEALTHCARE

Sector

VNDA Chart

Recent Chart
Price Action

VNDA Technicals

Tags:

VNDA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $187M
Total Revenue $199M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$41M
Selling General And Administrative $146M
Research And Development $74M
Operating Expenses $228M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.1M
Income Before Tax -$23M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$41M
Ebitda -$33M
Net Income -$19M

Revenue & Profitability

Earnings Performance

VNDA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $656M
Total Current Assets $439M
Cash And Cash Equivalents At Carrying Value $102M
Cash And Short Term Investments $102M
Inventory $1.7M
Current Net Receivables $47M
Total Non Current Assets $217M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $114M
Intangible Assets Excluding Goodwill $114M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $272M
Other Current Assets $15M
Other Non Current Assets -
Total Liabilities $118M
Total Current Liabilities $100M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $4.3M
Total Non Current Liabilities $18M
Capital Lease Obligations $12M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $12M
Other Current Liabilities $92M
Other Non Current Liabilities $9.6M
Total Shareholder Equity $539M
Treasury Stock -
Retained Earnings -$174M
Common Stock $58K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$16M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.1M
Capital Expenditures $490K
Change In Receivables -
Change In Inventory -$29K
Profit Loss -
Cashflow From Investment -$17M
Cashflow From Financing -$155K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$19M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $187M
Total Revenue $199M
Cost Of Revenue $11M
Costof Goods And Services Sold $11M
Operating Income -$41M
Selling General And Administrative $146M
Research And Development $74M
Operating Expenses $228M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.1M
Income Before Tax -$23M
Income Tax Expense -$4M
Interest And Debt Expense -
Net Income From Continuing Operations -$19M
Comprehensive Income Net Of Tax -
Ebit -$41M
Ebitda -$33M
Net Income -$19M

VNDA News

VNDA Profile

Vanda Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vanda Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Washington, D.C., dedicated to developing and commercializing innovative therapies aimed at addressing significant unmet medical needs in various therapeutic areas, including central nervous system disorders and sleep disorders. With a strong commitment to advancing patient care and a robust pipeline, Vanda leverages its scientific expertise to deliver transformative solutions to patients and healthcare providers alike. The company’s strategic focus on niche markets distinguishes it within the biopharmaceutical landscape, positioning it as a key player in pursuing growth opportunities and enhancing patient outcomes.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.